Compare · DWUS vs FTXH

DWUS vs FTXH

Side-by-side comparison of AdvisorShares Dorsey Wright FSM US Core ETF (DWUS) and First Trust Nasdaq Pharmaceuticals ETF (FTXH): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both DWUS and FTXH operate in n/a (n/a), so they compete in similar markets.
MetricDWUSFTXH
Company
AdvisorShares Dorsey Wright FSM US Core ETF
First Trust Nasdaq Pharmaceuticals ETF
Price
-
-
Market cap
-
-
1M return
-3.71%
-
1Y return
+6.62%
-
Sector
n/a
n/a
Industry
n/a
n/a
Exchange
NASDAQ
NASDAQ
IPO
n/a
n/a
News (4w)
0
0
Recent ratings
0
0
DWUS

AdvisorShares Dorsey Wright FSM US Core ETF

The investment seeks to provide long-term capital appreciation with capital preservation as a secondary objective. The fund is an actively managed exchange-traded fund ("ETF") that is primarily a "fund of funds." The Advisor seeks to achieve it's investment objective by investing in ETFs that invest primarily in domestic large capitalization equity securities. The fund invests in fixed income ETFs with a short or ultra-short duration, money market funds, cash and cash equivalents ("Defensive Investments"). It may invest in affiliated and unaffiliated ETFs. Under normal circumstances, the fund invests at least 80% of its net assets in U.S. investments.

FTXH

First Trust Nasdaq Pharmaceuticals ETF

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq US Smart Pharmaceuticals Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified.